605 related articles for article (PubMed ID: 26229137)
21. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
22. Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction.
Bin Waleed K; Lu Y; Liu Q; Zeng F; Tu H; Wei Y; Xu S; Zhang Z; Rongfeng Y; Fan A; Altaf A; Chang J; Wang L
Medicine (Baltimore); 2020 Jul; 99(27):e20794. PubMed ID: 32629663
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
[TBL] [Abstract][Full Text] [Related]
24. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
[TBL] [Abstract][Full Text] [Related]
25. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
26. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
Valdivielso JM; Coll B; Martín-Ventura JL; Moreno JA; Egido J; Fernández E; Blanco-Colio LM
J Nephrol; 2013; 26(6):1105-13. PubMed ID: 23475462
[TBL] [Abstract][Full Text] [Related]
27. Elevated Serum Trimethylamine N-Oxide Levels Are Associated with Mortality in Male Patients on Peritoneal Dialysis.
Fu D; Shen J; Li W; Wang Y; Zhong Z; Ye H; Huang N; Fan L; Yang X; Yu X; Zhou Y; Mao H
Blood Purif; 2021; 50(6):837-847. PubMed ID: 33596582
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
[TBL] [Abstract][Full Text] [Related]
29. The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.
Mente A; Chalcraft K; Ak H; Davis AD; Lonn E; Miller R; Potter MA; Yusuf S; Anand SS; McQueen MJ
Can J Cardiol; 2015 Sep; 31(9):1189-94. PubMed ID: 26239008
[TBL] [Abstract][Full Text] [Related]
30. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
[TBL] [Abstract][Full Text] [Related]
31. Plasma Trimethylamine N-Oxide Levels Are Associated with Poor Kidney Function in People with Type 2 Diabetes.
Kalagi NA; Thota RN; Stojanovski E; Alburikan KA; Garg ML
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839170
[TBL] [Abstract][Full Text] [Related]
32. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.
Dambrova M; Latkovskis G; Kuka J; Strele I; Konrade I; Grinberga S; Hartmane D; Pugovics O; Erglis A; Liepinsh E
Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):251-6. PubMed ID: 27123785
[TBL] [Abstract][Full Text] [Related]
33. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
Tang WHW; Li XS; Wu Y; Wang Z; Khaw KT; Wareham NJ; Nieuwdorp M; Boekholdt SM; Hazen SL
Am Heart J; 2021 Jun; 236():80-86. PubMed ID: 33626384
[TBL] [Abstract][Full Text] [Related]
34. Association Between Plasma Trimethylamine N-oxide and Neoatherosclerosis in Patients With Very Late Stent Thrombosis.
Tan Y; Zhou J; Liu C; Zhou P; Sheng Z; Li J; Chen R; Song L; Zhao H; Xu B; Gao R; Yan H
Can J Cardiol; 2020 Aug; 36(8):1252-1260. PubMed ID: 32595007
[TBL] [Abstract][Full Text] [Related]
35. Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort.
Gessner A; di Giuseppe R; Koch M; Fromm MF; Lieb W; Maas R
Clin Chem Lab Med; 2020 Apr; 58(5):733-740. PubMed ID: 32084001
[TBL] [Abstract][Full Text] [Related]
36. Higher serum trimethylamine N-oxide (TMAO) levels are associated with increased visceral fat in hemodialysis patients.
Bi SH; Su C; Yang P; Zhang X; Wang Y; Tang W; Yang W; He L
Clin Nephrol; 2023 Dec; 100(6):275-283. PubMed ID: 37877299
[TBL] [Abstract][Full Text] [Related]
37. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease.
Tomlinson JAP; Wheeler DC
Kidney Int; 2017 Oct; 92(4):809-815. PubMed ID: 28807612
[TBL] [Abstract][Full Text] [Related]
38. Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney Disease.
Prokopienko AJ; West RE; Schrum DP; Stubbs JR; Leblond FA; Pichette V; Nolin TD
Sci Rep; 2019 Nov; 9(1):15901. PubMed ID: 31685846
[TBL] [Abstract][Full Text] [Related]
39. Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease.
Bao M; Li H; Li J
BMC Cardiovasc Disord; 2024 May; 24(1):265. PubMed ID: 38773380
[TBL] [Abstract][Full Text] [Related]
40. The influence of renal transplantation on retained microbial-human co-metabolites.
Poesen R; Evenepoel P; de Loor H; Bammens B; Claes K; Sprangers B; Naesens M; Kuypers D; Augustijns P; Meijers B
Nephrol Dial Transplant; 2016 Oct; 31(10):1721-1729. PubMed ID: 26961998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
